Mild Age-Related Hearing Loss: DX243 Treatment

We are testing a new treatment for people with mild age-related hearing loss to see if it is safe and effective. The study starts with healthy volunteers before moving to patients.

>2 yearsSafety phase (I)Efficacy phase (II)Internal MedicineOtolaryngology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Advanced Technology Corporation
Inokura
Tilff, Belgium
Sponsor: Dendrogenix
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.